Alan Lamont

4.2k citations
54 papers · 3.2k · 2 hit papers · h-index 27

Impact in

    • Ovarian cancer diagnosis and treatment
  • Immunology top 5%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Immunotherapy and Immune Responses 11
    • T-cell and B-cell Immunology 11
    • Immune Cell Function and Interaction 11
    • Lung Cancer Research Studies 7
    • Cytokine Signaling Pathways and Interactions 3

Alan Lamont

53 papers receiving 3.1k citations

Alan Lamont's Hit Papers

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial 2010 · 364 citations
3640+7+15Years since publication250500750

Peers

Alan Lamont
Comparison fields: 5 of 108
  • Reproductive Medicine 861
  • Immunology 753
  • Oncology 900
  • Obstetrics and Gynecology 221
  • Immunology and Allergy 117
Replace Sharon P. Wilczynski with:
Sharon P. Wilczynski United States
Sepp Leodolter Austria
Stephen A. Cannistra United States
Joseph P. Connor United States
Tang‐Yuan Chu Taiwan
Mack N. Barnes United States
P Speiser Austria
A. G. Prentice United Kingdom
Iain A. McNeish United Kingdom
Pei Hui United States
Alan Lamont relative to Sharon P. Wilczynski United States Sharon P. Wilczynski's profile →
Citations per field
00.5×1.5×
Sharon P. Wilczynski · 1×
Citations per year

Countries citing papers authored by Alan Lamont

Since Specialization
Citations

This map shows the geographic impact of Alan Lamont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Lamont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Lamont more than expected).

Fields of papers citing papers by Alan Lamont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Lamont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Lamont. The network helps show where Alan Lamont may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Lamont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Lamont Line = papers co-authored together Alan Lamont links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Hit paper breakdown →
2003887
2
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
Hit paper breakdown →
2010364
3 2002192
4 1996186
5 1992148
6 1997143
7 2005112
8 199097
9 200777
10 199665
11 199056
12 200356
13 199855
14
Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice.
198948
15 199845
16 199941
17 200038
18 199238
19 199037
20 200135

About Alan Lamont

Alan Lamont is a scholar working on Immunology, Oncology, Molecular Biology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (11 papers), Immune Cell Function and Interaction (11 papers), Ovarian cancer diagnosis and treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Lung Cancer Research Studies (7 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Reproductive Medicine (861 citations), Immunology (753 citations), Oncology (900 citations), Obstetrics and Gynecology (221 citations) and Immunology and Allergy (117 citations). Alan Lamont has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mahesh Parmar, Gunnar B. Kristensen, Gordon C. Jayson, Irene Floriani, Valter Torri, Delaloye Jf, Andreas du Bois, C. Tropé, Nicoletta Colombo and Ann Marie Swart. Their work appears in journals such as The Journal of Immunology, Anti-Cancer Drugs, Clinical Oncology, European Journal of Immunology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact